103 related articles for article (PubMed ID: 9479645)
1. Effect of sofalcone on adherence, production of vacuolating toxin, and induction of interleukin-8 secretion by Helicobacter pylori.
Kamiya S; Osaki T; Kumada J; Yamaguchi H; Taguchi H
J Clin Gastroenterol; 1997; 25 Suppl 1():S172-8. PubMed ID: 9479645
[TBL] [Abstract][Full Text] [Related]
2. The effect of sofalcone on indomethacin-induced gastric ulcers in a Helicobacter pylori-infected gnotobiotic murine model.
Kabir AM; Shimizu K; Aiba Y; Igarashi M; Takagi A; Koga Y
Aliment Pharmacol Ther; 2000 Apr; 14 Suppl 1():223-9. PubMed ID: 10807428
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of sofalcone on tumor necrosis factor-alpha and interleukin-1 beta production in human monocytes stimulated by Helicobacter pylori water extract.
Fujiwara Y; Higuchi K; Fukuda T; Watanabe T; Tominaga K; Arakawa T
Drugs Exp Clin Res; 2001; 27(3):103-6. PubMed ID: 11447767
[TBL] [Abstract][Full Text] [Related]
4. A novel in vitro effect of the mucosal protective agent sofalcone--inhibition of chemotactic motility in Helicobacter pylori.
Yoshiyama H; Nakamura H; Okamoto T; Okita K; Nakazawa T
Aliment Pharmacol Ther; 2000 Apr; 14 Suppl 1():230-6. PubMed ID: 10807429
[TBL] [Abstract][Full Text] [Related]
5. Sofalcone for treatment of Helicobacter pylori infection.
Fujioka T; Murakami K; Kubota T; Kodama R; Honda S; Nasu M
J Gastroenterol; 1996 Nov; 31 Suppl 9():56-8. PubMed ID: 8959521
[TBL] [Abstract][Full Text] [Related]
6. The effect of Helicobacter pylori on gastric acid secretion by isolated parietal cells from a guinea pig. Association with production of vacuolating toxin by H. pylori.
Kobayashi H; Kamiya S; Suzuki T; Kohda K; Muramatsu S; Kurumada T; Ohta U; Miyazawa M; Kimura N; Mutoh N; Shirai T; Takagi A; Harasawa S; Tani N; Miwa T
Scand J Gastroenterol; 1996 May; 31(5):428-33. PubMed ID: 8734337
[TBL] [Abstract][Full Text] [Related]
7. Effects of anti-ulcer agents on antibiotic activity against Helicobacter pylori.
Sunairi M; Watanabe K; Suzuki T; Tanaka N; Kuwayama H; Nakajima M
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S121-4. PubMed ID: 7735928
[TBL] [Abstract][Full Text] [Related]
8. [Sofalcone].
Fukuda Y; Shimoyama T
Nihon Rinsho; 2002 Feb; 60 Suppl 2():704-9. PubMed ID: 11979875
[No Abstract] [Full Text] [Related]
9. Sofalcone, a gastroprotective drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori: a randomized controlled comparative trial with cimetidine, an H2-receptor antagonist.
Higuchi K; Watanabe T; Tanigawa T; Tominaga K; Fujiwara Y; Arakawa T
J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S155-60. PubMed ID: 20586860
[TBL] [Abstract][Full Text] [Related]
10. Sofalcone, a mucoprotective agent, increases the cure rate of Helicobacter pylori infection when combined with rabeprazole, amoxicillin and clarithromycin.
Isomoto H; Furusu H; Ohnita K; Wen CY; Inoue K; Kohno S
World J Gastroenterol; 2005 Mar; 11(11):1629-33. PubMed ID: 15786539
[TBL] [Abstract][Full Text] [Related]
11. The susceptibility of Campylobacter pylori to antiulcer agents and antibiotics.
Nagate T; Numata K; Hanada K; Kondo I
J Clin Gastroenterol; 1990; 12 Suppl 1():S135-8. PubMed ID: 2212539
[TBL] [Abstract][Full Text] [Related]
12. Flagellin gene diversity among Helicobacter pylori strains and IL-8 secretion from gastric epithelial cells.
Ohta-Tada U; Takagi A; Koga Y; Kamiya S; Miwa T
Scand J Gastroenterol; 1997 May; 32(5):455-9. PubMed ID: 9175206
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy with clarithromycin and sofalcone for eradication of Helicobacter pylori.
Kodama R; Fujioka T; Fujiyama K; Kawasaki H; Kubota T; Nasu M
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S125-8. PubMed ID: 7735929
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of gastric H+,K(+)-ATPase by the anti-ulcer agent, sofalcone.
Murakami S; Muramatsu M; Aihara H; Otomo S
Biochem Pharmacol; 1991 Sep; 42(7):1447-51. PubMed ID: 1656986
[TBL] [Abstract][Full Text] [Related]
15. Effect of rebamipide, a novel antiulcer agent, on Helicobacter pylori adhesion to gastric epithelial cells.
Hayashi S; Sugiyama T; Amano K; Isogai H; Isogai E; Aihara M; Kikuchi M; Asaka M; Yokota K; Oguma K; Fujii N; Hirai Y
Antimicrob Agents Chemother; 1998 Aug; 42(8):1895-9. PubMed ID: 9687380
[TBL] [Abstract][Full Text] [Related]
16. Lafutidine inhibits Helicobacter pylori-induced interleukin-8 production in human gastric epithelial cells.
Nozawa Y; Nishihara K; Akizawa Y; Orimoto N; Nakano M; Uji T; Ajioka H; Kanda A; Matsuura N; Kiniwa M
J Gastroenterol Hepatol; 2004 May; 19(5):506-11. PubMed ID: 15086593
[TBL] [Abstract][Full Text] [Related]
17. Relationship between expression of HSP60, urease activity, production of vacuolating toxin, and adherence activity of Helicobacter pylori.
Yamaguchi H; Osaki T; Taguchi H; Hanawa T; Yamamoto T; Kamiya S
J Gastroenterol; 1998; 33 Suppl 10():6-9. PubMed ID: 9840008
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of 15-hydroxy prostaglandin dehydrogenase and increase of prostaglandin E2: effect of sofalcone on rat gastric mucosa.
Muramatsu M; Tanaka M; Murakami S; Aihara H
Life Sci; 1987 Jul; 41(3):315-22. PubMed ID: 3474485
[TBL] [Abstract][Full Text] [Related]
19. Studies on the relationship between adhesive activity and haemagglutination by Helicobacter pylori.
Osaki T; Yamaguchi H; Taguchi H; Kumada J; Ogata S; Kamiya S
J Med Microbiol; 1997 Feb; 46(2):117-21. PubMed ID: 9060870
[TBL] [Abstract][Full Text] [Related]
20. Gastric urease activity is inversely associated with the success of treatment for Helicobacter pylori: effect of sofalcone.
Suzuki M; Kitahora T; Nagahashi S; Suzuki H; Mori M; Hibi T; Ishii H
J Clin Gastroenterol; 1998; 27 Suppl 1():S183-6. PubMed ID: 9872519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
